Concepedia

Mark J. Demma

MJ

Statistics

Publications

14

Citations

1.2K

H-Index

13

Active since

1990

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Albert Einstein College of Medicine

IRBM Science Park

Mark J. Demma is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, molecular biology, and cell biology.

Publications per year

1990–2020

14

Publications

14

Identification of an actin-binding protein from Dictyostelium as elongation factor 1a

Fan Yang, Mark J. Demma, Vivien A. Warren et al. · Nature · 1990 · 345 citations

Life Sciences, Cell Biology, Molecular Biology +10

Isolation of an abundant 50,000-dalton actin filament bundling protein from Dictyostelium amoebae.

Mark J. Demma, Vivien A. Warren, Randy A. Hock et al. · Journal of Biological Chemistry · 1990 · 108 citations · Full text

Life Sciences, Biochemistry, Cell Biology +11

SCH529074, a Small Molecule Activator of Mutant p53, Which Binds p53 DNA Binding Domain (DBD), Restores Growth-suppressive Function to Mutant p53 and Interrupts HDM2-mediated Ubiquitination of Wild Type p53

Mark J. Demma, Eugene Maxwell, Robert Ramos et al. · Journal of Biological Chemistry · 2010 · 106 citations · Full text

Life Sciences, Genetics, Molecular Biology +11

A novel p53 rescue compound induces p53-dependent growth arrest and sensitises glioma cells to Apo2L/TRAIL-induced apoptosis

Lasse Weinmann, Jörg Wischhusen, Mark J. Demma et al. · Cell Death and Differentiation · 2008 · 103 citations

Medicine, Oncology, Pharmacology +17

Omomyc Reveals New Mechanisms To Inhibit the MYC Oncogene

Mark J. Demma, Claudio Mapelli, Angie Sun et al. · Molecular and Cellular Biology · 2019 · 91 citations · Full text

Medicine, Molecular Biology, Oncology +16

1–5 of 14